TSE:MFC

Manulife Financial (MFC.TO)

60.69
+0.02 (0.03%)
as of Jul 23, 2026, 8:00:00 pm Market Open.
1632 watching
0
Investor Insights
star iconJul 23, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has garnered mixed perspectives from various analysts, reflecting both its potential and current market position. While many experts acknowledge MFC's solid dividend yield and growth prospects, particularly in Asia, concerns about valuation and market conditions persist. The stock appears to be trading around 2x book value and has shown slow but steady growth, attracting attention from those looking for income rather than explosive growth. The consensus among experts is to proceed with caution and consider market pullbacks for optimal entry points, though some view the stock as a good long-term hold due to its stable dividend and cash flow. Overall, while there are positive signs, such as asset management improvements and capital growth, analysts advise careful monitoring given the mixed signals surrounding the broader financial sector's performance.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Fair Value
review icon
Similar
SLF
DON'T BUY
Hasn't owned for several years. Doesn't know if it is worth the risk at this price. Not worth chasing. Prefers Great West (GWO-T), which has a 5% yield.
SELL
Nobody knows where this company is going to go from here. Pure speculation.
BUY ON WEAKNESS
Difficult story. Would probably buy if it got to $10 again. Missed their capital ratios and investors feel they are very much tied to the equity market. Very hard for insurance companies to operate in this low interest-rate environment.
SELL
Both MFC and SLF have exposure to an annuity product that was sold during the bull market. People are fixated on the hedging on this. He would not be standing there to catch these names. There are insurance names that are not in these products. Move into another insurance name.
HOLD
Is a longer-term play. No dividend increases for next couple of years. Volatile. Might come down a bit more. Too cheap to bail out.
COMMENT
7.768% bond due 4/8/19? Risk currently is dilution. Doesn't see any default risk. Once company issues equity or reduces dividend there should be an improvement in these bonds. Fairly priced right now. Prefers buying lower dollar bonds.
TOP PICK
If you believe this market is bottoming and will work higher, this is like a warrant on the market. Oversold. Historically at a historical level +30% below its moving average. This is only happened once before.
WATCH
If rates go lower, this company will have a tough time. Wouldn't touch at this time. If it moves up above $12.80 he would be interested.
WAIT
Doesn’t see a takeover. This is a contrarian play and is on his watch list.
COMMENT
Have been through hell in every sense and he thinks it is probably near the low. If you have gains elsewhere and a big loss here, you might want to take the loss. Probably in for another couple of tough quarters. If your timeframe is 18-24 months and your patient, you should do fine.
HOLD
Thinks there is a window of opportunity in the next 24 months as they get their house in order and become less dependent on equity market performance.
BUY
7.768% Medium Term Note due 4/08/19? There is still AA rating on this company. This is a very strong, solid, investment grade rating. He would be very comfortable with this.
TOP PICK
7.405% bond due 31/12/19.
WATCH
All lifecos’ earnings became more volatile when securities had to be marked to market and had to relate to guarantees made on fixed incomes. If markets continue up, he could see a rebound in the September quarter. Before buying he would like to see stability in markets and rising stock prices on a consistent basis.
DON'T BUY
Sold his holdings when they discovered that it wasn't just an insurance company but was a leveraged product on the US stock market. With 51% of their portfolios still unhedged, you still own a highly leveraged stock market.
Showing 1,426 to 1,440 of 2,283 entries